Comparative Real-Life Effectiveness and Safety of Dabigatran or Rivaroxaban vs. Vitamin K Antagonists: A High-Dimensional Propensity Score Matched New Users Cohort Study in the French National Healthcare Data System SNDS

Citation
Blin P, Dureau-Pournin C, Bénichou J, et al. Am J Cardiovasc Drugs 2020;20(1):81-103.